Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology International"
DOI: 10.1007/s12072-019-09933-8
Abstract: BackgroundMedical treatment of decompensated cirrhosis due to hepatitis C virus (HCV) remains a clinical challenge even in the era of direct-acting antiviral drugs (DAAs). We evaluated the efficacy and safety of DAAs in the management… read more here.
Keywords: cirrhosis; direct acting; acting antiviral; decompensated cirrhosis ... See more keywords